Cargando…
Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects
Cancer metabolic plasticity, including changes in fatty acid metabolism utilisation, is now widely appreciated as a key driver for cancer cell growth, survival and malignancy. Hence, cancer metabolic pathways have been the focus of much recent drug development. Perhexiline is a prophylactic antiangi...
Autores principales: | Dhakal, Bimala, Tomita, Yoko, Drew, Paul, Price, Timothy, Maddern, Guy, Smith, Eric, Fenix, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145508/ https://www.ncbi.nlm.nih.gov/pubmed/37110858 http://dx.doi.org/10.3390/molecules28083624 |
Ejemplares similares
-
Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
por: Dhakal, Bimala, et al.
Publicado: (2023) -
The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing
por: Dhakal, Bimala, et al.
Publicado: (2022) -
Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis
por: Li, Celine Man Ying, et al.
Publicado: (2023) -
Elimination of Chronic Lymphocytic Leukemia Cells in Stromal Microenvironment by Targeting CPT with an Anti-Angina Drug Perhexiline
por: Liu, Pan-pan, et al.
Publicado: (2016) -
Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2023)